保健品：斐萃上新红宝石油新品，新品牌成功确定性强斐萃基于独家原料红宝石油推新小红瓶：红宝石 油为女性专研高阶鱼油，成分包含虾青素、SDA、普利醇、EPA、DHA 等，独有蜡酯结构使得吸收率 达普通鱼油2 倍，核心功效包含提代谢（减脂增肌）、抗氧力（亮白肌肤）、抗炎等。 展望空间：绽家定位于家清领域消费升级，以"高端香氛"切口切入，提供高感知价值契合消费升级趋 势，其兼具替代刚需+拓展体验双重潜力。 投资建议：绽家斐萃差异化定位高端香氛家清/口服美容，挖掘新消费场景，双渠道、多爆品驱动增长 确定性延续,独家原料红宝石油有望成为重要增量驱动，同时基于前述逻辑我们认为红宝石油新品牌打 造确定性很高；对于绽家和斐萃的精准定位，凸显了公司的前瞻眼光与清晰成长路径，未来有望聚焦核 心女性人群，深挖细分需求场景，打造"小而美"特色细分品牌矩阵，展望绽家持续场景破圈＆大健康品 牌矩阵持续兑现放量。我们认为若羽臣基于人群资产和管理者前瞻眼光具备长期成长性，值得被溢价。 风险提示：行业竞争加剧；营销投放费用管控不达预期；新品牌孵化风险；新品类培育团队不达要求 等。 新品牌具备高确定性：后续预计将以红宝石油为核心成分推出新品牌，斐 ...

今天分享的是：面向未来-2025年中国面膜市场创新动向与全球消费趋势报告 报告共计：108页 2025年中国面膜市场创新动向与全球消费趋势总结 一、市场规模与增长特征 2025年中国面膜线上市场规模达484亿元，抖音以260亿元GMV、32%增速领跑，超越淘宝天猫成为核心增长引擎。贴片面膜仍 为主流（抖音占比89%），但涂抹面膜爆发式增长（抖音同比+174.77%），展现差异化增长潜力。全球市场方面，2025年全球 面膜GMV预计200-250亿美元，2030年将达300-400亿美元，亚太地区（尤其中国、印度）消费升级与技术迭代为主要驱动力。 二、核心消费趋势与产品创新 1. 功效与情绪价值双轮驱动 消费者需求从"成分内卷"转向"情绪价值"，"悦己护肤"声量同比激增2169%，面膜成为自我疗愈的仪式感载体。功效层面，抗衰 品类占19%市场份额，但42%消费者痛点聚焦屏障修护，倒逼产品向"细胞级精准响应"升级，如生物智造、AI定制等技术应用。 2. 技术革新重塑产品形态 - 膜布创新：植物纤维与莱赛尔膜布占据超50%市场，环保性与功效性协同升级，超声波复合膜布（同比+672%）等多层结构技 术提升精华渗透率。 ...

Group 1 - The beauty care sector is experiencing a significant downturn, with Bawei Co., Ltd. seeing a drop of over 10% in its stock price [1] - Other companies in the industry, such as Qingsong Co., Huaye Fragrance, Jieya Co., Liangmian Needle, and Shanghai Jahwa, are also facing notable declines in their stock prices [1]

证券研究报告 | 策略点评 2025 年 05 月 15 日 投资要点 分析师：孟之绪 执业编号：S0300524080001 电话： 邮箱：mengzhixu@ykzq.com 投资策略研究 粤开市场日报-20250515 今日关注 指数涨跌情况：今日 A 股主要宽基指数多数下跌。截止收盘，沪指跌 0.68%， 收报 3380.82 点；深证成指跌 1.62%，收报 10186.45 点；创业板指跌 1.92%， 收报 2043.25 点；科创 50 跌 1.26%，收报 1000.97 点。总体上全天个股涨少 跌多，Wind 数据显示，全市场 1406 只个股上涨，3856 只个股下跌，149 只个 股收平。沪深两市今日成交额合计 11524 亿元，较上个交易日缩量约 1643 亿 元。 行业涨跌情况：今日申万一级行业涨少跌多，仅美容护理、煤炭、公用事业 和农林牧渔行业上涨，涨幅分别为 3.68%、0.42%、0.12%和 0.11%，计算机、 通信、电子、传媒和国防军工行业领跌，跌幅分别为 2.97%、2.45%、2.12%、 1.93%、1.80%。 板块涨跌情况：今日涨幅居前概念板块为连板、医疗美容 ...

Core Viewpoint - The beauty and personal care sector is experiencing a strong resurgence, with stocks such as Lafang Home and others seeing significant gains due to multiple driving factors including policy benefits, consumer recovery, and ongoing trade tensions [1] Group 1: Stock Performance - Lafang Home has reached its daily limit increase [1] - Other companies such as Shuiyang Co., Bavi Co., Proya, Runben, Jieya, Beitaini, Zhongshun Jierou, and Fulejia have also seen stock price increases [1] Group 2: Industry Drivers - The cosmetics and medical beauty industry is showing a stable and positive development trend [1] - Factors contributing to this trend include the continuous release of policy dividends, recovery in consumer spending, and the escalation of trade frictions [1]

The Beauty Health Company (SKIN) Q1 2025 Earnings Call May 08, 2025 04:30 PM ET Company Participants Norberto Aja - Investor RelationsMarla Beck - President & CEOMichael Monahan - CFOJonathan Block - Managing DirectorSarah Whitaker Clemente - Director, Healthcare Conference Call Participants None - AnalystSusan Anderson - Managing Director & Senior AnalystBruce Jackson - Senior AnalystNavann Ty - Analyst Operator and welcome to today's Beauty Health Company First Quarter twenty twenty five Earnings Call. At ...

The Beauty Health Company (SKIN) Q1 2025 Earnings Call May 08, 2025 04:30 PM ET Speaker0 and welcome to today's Beauty Health Company First Quarter twenty twenty five Earnings Call. At this time, all participants are in a listen only mode. Later, you will have the opportunity to ask a question during the question and answer session. Please note this call is being recorded and I will be standing by if you should need any assistance. It is now my pleasure to turn the conference over to Norberto Ajah, Investor ...

Core Insights - The medical beauty sector experienced a slight increase of 0.53% on May 8, with a total capital outflow of 224.7 million [1] - A total of 43 stocks in the sector rose, while 21 stocks declined [1] Top Gainers - The top ten gainers in the sector included: - Aipeng Medical: +13.1% - Haochen Medical: +9.85% - Guangyunda: +9.8% - ST Jingfeng: +5.01% - ST Biological: +4.98% - Hangzhou Jiebai: +4.34% - Langzi Co.: +4.11% - Hanyu Pharmaceutical: +2.7% - Xinyaqiang: +1.57% - Dezhan Health: +1.29% [1] Top Losers - The stocks with the largest declines included: - Hanshang Group: -9.99% - Lafang Cosmetics: -6.79% - Changshan Pharmaceutical: -5.7% - ST Suwu: -4.84% - Chaohongji: -4.75% [1]

证券研究报告 | 策略点评 2025 年 04 月 29 日 投资要点 分析师：孟之绪 执业编号：S0300524080001 电话： 邮箱：mengzhixu@ykzq.com 投资策略研究 粤开市场日报-20250429 今日关注 指数涨跌情况：今日 A 股主要宽基指数涨跌各半。截止收盘，沪指跌 0.05%， 收报 3286.65 点；深证成指跌 0.05%，收报 9849.80 点；创业板指跌 0.13%， 收报 1931.94 点；科创 50 涨 0.10%，收报 1003.87 点。总体上全天个股涨多 跌少，Wind 数据显示，全市场 3556 只个股上涨，1670 只个股下跌，184 只个 股收平。沪深两市今日成交额合计 10221 亿元，较上个交易日缩量约 342 亿 元。 行业涨跌情况：今日申万一级行业涨跌各半，美容护理、机械设备、传媒、 轻工制造和基础化工行业领涨，涨幅分别为 2.60%、1.44%、1.27%、1.04%和 0.87%，公用事业、综合、石油石化、煤炭和社会服务行业领跌，跌幅分别为 1.78%、0.97%、0.55%、0.51%和 0.47%。 板块涨跌情况：今日涨幅居前概念 ...

InMode (INMD) Q1 2025 Earnings Call April 28, 2025 08:30 AM ET Company Participants Miri Segal - Founder & CEOMoshe Mizrahy - Chairman and Chief Executive OfficerYair Malca - CFOMatt Taylor - Managing DirectorCaitlin Cronin - DirectorSam Eiber - Vice President - Equity ResearchDane Reinhardt - Senior Equity Research Associate Conference Call Participants Matt Miksic - Equity Research AnalystDanielle Antalffy - AnalystMike Matson - Senior Equity Research Analyst Operator Good day and welcome to InMode's Firs ...